Author

M. Pizzato

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Caruso· 1 shared A. Corbelli· 1 shared A. De Luigi· 1 shared A. Gagliardi· 1 shared A. Grandi· 1 shared A. Piotti· 1 shared C. Bertelli· 1 shared C. Fracasso· 1 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Caruso

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of SARS-CoV-2 infectivity

L. Diomede, S. Baroni, A. De Luigi, A. Piotti, J. Lucchetti, C. Fracasso, L. Russo, V. Bonaldo, N. Panini, F. Filippini, F. Fiordaliso, A. Corbelli, M. Beeg, M. Pizzato, F. Caccuri, , M. Salmona

This paper tests doxycycline's effect on SARS-CoV-2 infection using pseudovirus and clinical strains, finding it inhibits pseudovirus transduction but not actual SARS-CoV-2 entry and replication.

bioRxiv · Jul 30, 2021Pharmacology & Toxicology

Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine

A. Grandi, M. Tomasi, S. Accordini, C. Bertelli, T. Vanzo, A. Gagliardi, E. Caproni, S. Tamburini, L. Fantappie, G. Di Lascio, Z. Bisoffi, C. Piubelli, M. T. Valenti, L. Dalle Carbonare, D. Zipeto, , G. Grandi

This study demonstrates that OMV-based SARS-CoV-2 vaccines induce neutralizing antibodies and protect mice from viral challenge.

bioRxiv · Jul 12, 2021 · PreprintImmunology

Influence of different glycoproteins and of the virion core on SERINC5 antiviral activity

W. E. Diehl, M. H. Guney, P. P. Kyawe, J. M. White, M. Pizzato, J. Luban

This study investigates how retroviral glycoproteins and cores influence SERINC5 antiviral activity, finding that sensitivity depends on both factors.

bioRxiv · Sep 24, 2019Microbiology